Moderna Halts Plan for Japan mRNA API Facility Amid Market Shifts, Completes Enzymatics R&D Site at Shonan iPark

Moderna provided an update on its two planned research and manufacturing facilities at Shonan Health Innovation Park (iPark) in Fujisawa, Kanagawa Prefectu...

July 22, 2025 | Tuesday | News
Longeveron Licenses Breakthrough Stem Cell Patent to Expand Cardiac Regenerative Pipeline

 Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening, ra...

July 22, 2025 | Tuesday | News
AstraZeneca Unveils $50 Billion U.S. Investment to Drive Innovation and Build World’s Largest Manufacturing Site in Virginia

Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US Cornerstone of investment is...

July 22, 2025 | Tuesday | News
Gelteq Partners with IDT Australia to Establish Dedicated Manufacturing Facility for Global Gel-Based Therapeutics

Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company focused on developing and commercializing white ...

July 21, 2025 | Monday | News
Korean Study Reveals Toxic Effects of Airborne Fungi at Levels Below Current Guidelines

Airborne microorganisms, including fungi and bacteria, are major contributors to indoor air pollution, with growing links to respiratory diseases. In a r...

July 18, 2025 | Friday | Reports
10x Genomics and A*STAR GIS Launch Landmark Spatial Biology Study in Asia to Drive Cancer and Inflammation Breakthroughs

Ambitious study will profile thousands of tumor samples to uncover novel biomarkers and therapeutic targets for cancer and inflammatory diseases 10x Gen...

July 18, 2025 | Friday | News
Oragenics Partners with Sterling Pharma for U.S.-Based GMP Manufacturing of Intranasal Concussion Drug ONP-002

Oragenics, Inc., a biotechnology company developing intranasal therapeutics for brain-related conditions, today announced it has entered into a manufactu...

July 17, 2025 | Thursday | News
Amphista Therapeutics Reaches Discovery Milestone in Merck Collaboration for Next-Gen Protein Degraders

Amphista Therapeutics (“the Company” or “Amphista”), a leader in the discovery of next-generation, Targeted Protein Degradation (...

July 17, 2025 | Thursday | News
Addgene and Promega Launch Plasmid Collection to Accelerate Drug Discovery Research

Addgene, a purpose-driven organization helping scientists conduct experiments with greater ease, speed, and reproducibility,  announced a strategic ...

July 16, 2025 | Wednesday | News
Thermo Fisher Launches Rapid CGP Solution on Genexus System to Advance Precision Oncology

Thermo Fisher Scientific announced that the Oncomine™ Comprehensive Assay Plus* is now available on the Ion Torrent™ Genexus™ System* h...

July 15, 2025 | Tuesday | News
Trethera’s TRE-515 Receives FDA Fast Track Designation for Advanced Prostate Cancer Treatment

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune d...

July 11, 2025 | Friday | News
Secarna and Vect-Horus Join Forces to Unlock RNA Therapeutics for CNS Disorders

  The partnership combines Secarna’s OligoCreator® technology with Vect-Horus’ VECTrans® platform to enable system...

July 11, 2025 | Friday | News
Certara Expands Partnership with Merck to Advance Metadata and Data Standards Management

Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced a new collaboration with Merck, known as MSD outside of...

July 09, 2025 | Wednesday | News
Synfini Secures $8.9M to Accelerate AI-Driven Chemistry Automation, Bringing Total Funding to $53M

Synfini, Inc., a trailblazer in AI-driven chemistry automation, today announced a $8.9 million expansion of its round, led by JSL Health Capital and supp...

July 08, 2025 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close